GH AMEA CEO appointed as Industry Representative to the National Health Innovation Centre Oversight Committee
Home » GH AMEA CEO appointed as Industry Representative to the National Health Innovation Centre Oversight Committee

GH AMEA on Social MediaGH AMEA CEO appointed as Industry Representative to the National Health Innovation Centre Oversight Committee
GH AMEA CEO appointed as Industry Representative to the National Health Innovation Centre Oversight Committee
GH AMEA CEO appointed as Industry Representative to the National Health Innovation Centre Oversight Committee
LinkedIn

We are proud to share our CEO, Mr. Simranjit Singh has recently been appointed to the National Health Innovation Centre Oversight committee under the Ministry of Health as an Industry representative. The National Health Innovation Centre Singapore provides the publicly-funded clinical research sector of Singapore with translational funding and strategic guidance to accelerate healthcare innovation.

Open chat
Message us